SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914475-24-000138
Filing Date
2024-05-21
Accepted
2024-05-21 17:35:30
Documents
1
Period of Report
2024-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1716327316.html 4  
1 FORM 4 wk-form4_1716327316.xml 4 7463
  Complete submission text file 0000914475-24-000138.txt   8923
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Issuer) CIK: 0000914475 (see all company filings)

IRS No.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Sharp Shalini (Reporting) CIK: 0001377202 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22705 | Film No.: 24970909